Obesity Market Forecast

The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513.7m sales in 2008 fall far short of analyst predictions.

Reasons to Purchase

• Understand why predictions for this market have been repeatedly over-stated
• Qualify market expectations against the practicalities of targeting this unyielding market
• Assess the qualities of marketed and pipeline products and their commercial handling to determine their realistic prospects